TransMedics Group, Inc. <TMDX.O>: UBS cuts target price to $77 from $80
TMDX•Related News
CoStar CEO Andrew Florance acquires 83,300 shares worth $2.49 million
CSGP•
AbbVie <ABBV.N>: Leerink Partners raises target price to $279 from $245
ABBV•
NASDAQ Trade Halt <JDZG.O> Volatility Trading Pause at 09:49 AM
JDZG•
Clear communication of Fed's 'reaction function' is helpful, Kashkari says
TLT•
FitLife Brands updates financial calendar with quarterly results release and investor call
FTLF•